"Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section"
BREATHE-CS
"The Effect of a 5-Minute Mindfulness-Based Breathing Exercise Administered Prior to Spinal Anesthesia on Hemodynamic Response in Patients Undergoing Elective Cesarean Section: A Prospective Randomized Controlled Trial"
1 other identifier
interventional
150
1 country
1
Brief Summary
Spinal anesthesia-induced hypotension is one of the most frequent and clinically significant complications of obstetric anesthesia, occurring in up to 50-80% of parturients undergoing elective cesarean section. Preoperative anxiety has been shown to potentiate hemodynamic instability through autonomic nervous system activation, thereby increasing susceptibility to spinal hypotension. This prospective, randomized, controlled trial aims to evaluate the effect of a standardized 5-minute mindfulness-based breathing exercise administered immediately prior to spinal anesthesia on the hemodynamic response in pregnant women scheduled for elective cesarean section. Eligible participants will be randomized in a 1:1 ratio into two parallel groups: the Mindfulness-Based Breathing Exercise Group and the Control Group receiving standard preoperative care. The breathing intervention consists of slow diaphragmatic breathing at a rate of approximately 6 breaths per minute (4-second inhalation through the nose, 6-second exhalation through the mouth), guided by a standardized script delivered by a trained anesthesiologist or nurse. Participants in the intervention group will be instructed to silently repeat the phrase "My body is relaxing as I exhale" with each exhalation, incorporating a mindfulness component. The primary outcome is the maximum decrease in systolic arterial pressure (SAP) within the first 10 minutes following spinal anesthesia induction. Secondary outcomes include preoperative state anxiety scores (STAI-5), early spinal hypotension incidence, heart rate changes, and vasopressor requirements. The study will be conducted at Atatürk University Faculty of Medicine, Department of Anesthesiology and Reanimation, Erzurum, Turkey, in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
March 18, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
April 1, 2026
March 1, 2026
2 years
March 18, 2026
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum Decrease in Systolic Arterial Pressure (ΔSAP_max) Following Spinal Anesthesia
he primary outcome is the maximum decrease in systolic arterial pressure (SAP) within the first 10 minutes following spinal anesthesia induction, calculated as the difference between the SAP value measured immediately prior to spinal anesthesia (T1, reference value) and the lowest SAP value recorded during the first 10 minutes post-spinal (SAP\_min). Formula: ΔSAP\_max = SAP\_T1 - SAP\_min (mmHg). SAP will be measured non-invasively at 1-minute intervals during the first 10 minutes following spinal induction.
Up to 10 minutes following spinal anesthesia induction"
Secondary Outcomes (7)
Change in Preoperative State Anxiety Score (ΔSTAI-S5)
"Baseline and up to 5 minutes prior to spinal anesthesia induction"
Incidence of Early Spinal Hypotension
"Up to 10 minutes following spinal anesthesia induction"
Maximum Heart Rate Decrease (ΔHR_max) Following Spinal Anesthesia
"Up to 10 minutes following spinal anesthesia induction"
Time to First Hypotensive Episode
"During surgery, up to approximately 60 minutes following spinal anesthesia induction"
Proportion of Participants Requiring Vasopressor Therapy
"Up to 10 minutes following spinal anesthesia induction"
- +2 more secondary outcomes
Study Arms (2)
Arm 1 Title: Mindfulness-Based Breathing Exercise Group
EXPERIMENTALParticipants allocated to this arm will receive a standardized 5-minute mindfulness-based breathing exercise immediately prior to spinal anesthesia induction. The intervention will be administered by a trained anesthesiologist or nurse using a standardized script. The breathing protocol consists of slow diaphragmatic breathing at approximately 6 breaths per minute, with a 4-second nasal inhalation followed by a 6-second oral exhalation. During each exhalation, participants will be instructed to silently repeat the phrase "My body is relaxing as I exhale," incorporating a mindfulness-based cognitive component. The exercise will be performed in a comfortable position in the operating room following establishment of standard monitoring (ECG, non-invasive blood pressure, SpO₂).
Arm 2 Title: Control Group
NO INTERVENTIONParticipants allocated to this arm will receive standard preoperative care without any breathing exercise, relaxation technique, or mindfulness-based intervention. Following establishment of standard monitoring (ECG, non-invasive blood pressure, SpO₂) in the operating room, participants will wait for the equivalent duration before spinal anesthesia induction, consistent with routine clinical practice at the study center.
Interventions
"A standardized 5-minute mindfulness-based breathing exercise at approximately 6 breaths per minute (4-second nasal inhalation, 6-second oral exhalation), guided by a trained anesthesiologist or nurse using a standardized verbal script. During each exhalation, participants silently repeat: 'My body is relaxing as I exhale.'"
Eligibility Criteria
You may qualify if:
- Pregnant women aged 18-45 years Singleton pregnancy Gestational age 37 weeks or greater American Society of Anesthesiologists (ASA) physical status classification II Scheduled for elective cesarean section under spinal anesthesia Body mass index (BMI) 35 kg/m2 or less Ability to comprehend verbal instructions and perform the breathing exercise Provision of written informed consent
You may not qualify if:
- Emergency cesarean section Hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, HELLP syndrome) Placenta previa, placental abruption, or active antepartum hemorrhage Multiple pregnancy Contraindications to spinal anesthesia Failed spinal anesthesia requiring conversion to general anesthesia Chronic hypertension or chronic hypotension Known cardiac disease (arrhythmia, valvular disease, cardiomyopathy) Diabetes mellitus with autonomic neuropathy Thyroid dysfunction Chronic pulmonary disease potentially affecting respiratory pattern Body mass index greater than 35 kg/m2 Regular use of beta-blockers, calcium channel blockers, alpha-agonists, or alpha-antagonists Regular use of anxiolytics, antidepressants, sedatives, or chronic opioids Diagnosed anxiety disorder, panic disorder, major depressive disorder, or other psychiatric illness Regular use of psychiatric medications Cognitive impairment or communication difficulties Attention or compliance problems precluding adequate performance of the breathing exercise Prior regular practice of meditation, yoga, or mindfulness-based training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aysenur Dostbillead
Study Sites (1)
Atatürk University Research Hospital
Erzurum, 25240, Turkey (Türkiye)
Related Publications (4)
Walker AP, McCormack ML, Messier J, Myers-Smith IH, Wullschleger SD. Trait covariance: the functional warp of plant diversity? New Phytol. 2017 Dec;216(4):976-980. doi: 10.1111/nph.14853. No abstract available.
PMID: 29110312BACKGROUNDTeixeira AG, Silva AS, Lin FL, Velletri R, Bavia L, Belfort R Jr, Isaac L. Association of complement factor H Y402H polymorphism and age-related macular degeneration in Brazilian patients. Acta Ophthalmol. 2010 Aug;88(5):e165-9. doi: 10.1111/j.1755-3768.2010.01932.x. Epub 2010 Jul 6.
PMID: 20626361BACKGROUNDRusso MA, Santarelli DM, O'Rourke D. The physiological effects of slow breathing in the healthy human. Breathe (Sheff). 2017 Dec;13(4):298-309. doi: 10.1183/20734735.009817.
PMID: 29209423BACKGROUNDShaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. doi: 10.3389/fpubh.2017.00258. eCollection 2017.
PMID: 29034226BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
kamber kaşali
Atatürk University Faculty of Medicine, Department of Biostatistics, Erzurum, Turkey
- STUDY DIRECTOR
gamze nur cimilli şenocak, MD
Atatürk University Faculty of Medicine, Department of Obstetrics and Gynecology, Erzurum, Turkey
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Due to the nature of the intervention, blinding of participants and care providers is not feasible in this trial. However, outcome assessor blinding will be implemented to minimize measurement bias. Hemodynamic data (systolic arterial pressure, heart rate, and peripheral oxygen saturation) will be recorded prospectively by a designated investigator who is blinded to group allocation and has no involvement in the administration of the breathing exercise or the randomization process. This single-blind design ensures that primary and secondary hemodynamic outcome measurements are obtained independently of treatment assignment, thereby reducing the risk of assessment bias.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Anesthesiology and Reanimation
Study Record Dates
First Submitted
March 18, 2026
First Posted
March 27, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
"Individual participant data will not be shared, as this is an academic thesis study conducted at a single center. Patient confidentiality will be maintained in accordance with applicable data protection regulations. Anonymized aggregate results will be reported in the final publication."